Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
||
|
NDF-RT |
N0000175657
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
||
|
WHO-ATC |
L04AA36
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
637334-45-3
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
8636
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
Ocrelizumab
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108041
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
QQ-93
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
A10SJL62JY
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
1876366
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
100000144876
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
SUB121707
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
5223
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
DB11988
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
Ocrelizumab
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
C66250
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
m12020
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY | |||
|
A10SJL62JY
Created by
admin on Fri Dec 15 16:07:36 GMT 2023 , Edited by admin on Fri Dec 15 16:07:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY